Alcon Research: Clinical Trials

782 trials sponsored by Alcon Research, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

657 completed, 49 terminated, 29 withdrawn, 20 recruiting. 367 Not applicable, 152 Phase 4, 114 Phase 3, 69 Phase 2, 17 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable367Completed 321, Withdrawn 12, Terminated 10, Recruiting 8, Unknown 8, Active not recruiting 7, Not yet recruiting 1
Phase 4152Completed 125, Terminated 11, Withdrawn 6, Recruiting 5, Not yet recruiting 4, Unknown 1
Phase 3114Completed 96, Terminated 10, Withdrawn 5, Recruiting 2, Unknown 1
Phase 269Completed 54, Terminated 10, Withdrawn 4, Active not recruiting 1
Phase 117Completed 12, Terminated 2, Withdrawn 2, Active not recruiting 1

Follow Alcon Research: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cooling Eyedrops for Dry Eye
TRYPTYR Eye Drops, Purilens Plus Non-Preserved Saline Eye Drops - Dry Eye
Phase 4Not yet recruitingUniversity of California, Berkeley502026-11-012026-10-26
Evaporative Dry Eye
acoltremon 0.003%. - Dry Eye, Evaporative Dry Eye
Phase 4Not yet recruitingSouthern College of Optometry412026-10-262026-10-28
Clinical Evaluation of a Novel Trifocal IOL
LPYWT0, PXYWT0, Cataract Surgery - Aphakia, Cataract
Not applicableRecruitingAlcon Research662026-10-092026-10-21
Effect of Acoltremon Ophthalmic Solution 0.003% on Tear Production and Symptoms in Patients With Tear Deficiency and Concurrent Neuropathic Corneal Pain
acoltremon ophthalmic solution 0.003% - Ocular Pain, Dry Eye
Phase 4Not yet recruitingUniversity of South Florida282026-10-012026-10-06
Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients
Netarsudil 0.02% Ophthalmic Solution [RHOPRESSA], Timolol Maleate 0.25% Ophthalmic Solution - Open Angle Glaucoma (OAG), Glaucoma
Phase 4RecruitingBrett King132026-10-012026-10-28
Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in Adults
Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free, Vehicle - Ocular Hyperemia
Phase 3RecruitingAlcon Research2302026-09-302026-10-16
An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults
Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free, Vehicle - Ocular Hyperemia
Phase 3RecruitingAlcon Research1782026-09-272026-11-12
UNITY DX Cornea Study
UNITY DX, ANTERION - Tomography
RecruitingAlcon Research1102026-09-242026-11-12
Agreement of Two OCT Biometers: A Pilot Study
UNITY DX, ANTERION - Anterior Segment of Eye, Axial Length
RecruitingAlcon Research502026-08-172026-09-02
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
Rocklatan (Netarsudil 0.02%/ latanoprost 0.005), Latanoprost (0.005%) - Ocular Hypertension, Suspect Glaucoma
Phase 4RecruitingUniversity of Maryland, Baltimore502026-07-022026-07-02
Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension
Netarsudil Ophthalmic Solution (Rhopressa), Artificial Tears (AT) - Glaucoma, Ocular Hypertension
Phase 4RecruitingIndiana University502026-06-052026-06-11
Evaluation of Tears Naturale® Free and Tears Naturale® II Lubricant Eye Drops
Tears Naturale Free lubricating eye drops, Tears Naturale II lubricating eye drops - Dry Eye Disease
Not applicableCompletedAlcon Research1322026-06-042026-10-07
P1 Toric Vs. Max 1day
, silicone hydrogel (lehfilcon A) soft contact lens (CL) with SMARTSURFACE Technology and UV protection - Eye, Astigmatism
Not applicableActive not recruitingSouthern College of Optometry322026-05-272026-11-04
Clareon TruPlus Study
Clareon TruPlus Monofocal Non-Toric IOL, Clareon TruPlus Monofocal Toric IOL, Phacoemulsification - Aphakia, Astigmatism
Not applicableRecruitingAlcon Research1852026-05-262026-10-30
Refitting Satisfied INFUSE One-Day Multifocal Wearers to DAILIES TOTAL1 Multifocal Contact Lenses
DAILIES TOTAL1 Multifocal (delefilcon A) - Contact Lens Comfort and Successful Refitting, Presbyopia
Not applicableRecruitingGordon Schanzlin New Vision302026-05-202026-06-11
Contralateral Claims Study of Clareon Vivity Pro
Clareon Vivity Pro IOL, Clareon Vivity IOL, TECNIS PureSee IOL - Aphakia, Presbyopia
Not applicableActive not recruitingAlcon Research1652026-04-282026-11-09
Wear Experience With Daily Disposable Contact Lenses for Astigmatism Over a Long-Wear Day
Daily disposable contact lenses for astigmatism - Astigmatism
Not applicableRecruitingOhio State University402026-03-042026-09-25
An Evaluation of the Safety and Tolerability of Ocular Lubricants
FID123440 test formulation, FID123437 test formulation - Dry Eye Disease
Not applicableCompletedAlcon Research1242026-03-042026-08-11
Comparison of Ocular Lubricants in People With Symptoms of Dry Eye
Propylene glycol 0.6%, 3% trehalose and 0.15% sodium hyaluronate - Dry Eye Symptoms
Phase 4CompletedUniversity of Waterloo362026-02-232026-09-01
SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease
SYSTANE® PRO, MIEBO™ (Perfluorohexyloctane, PFHO) - Dry Eye Disease (DED)
Phase 4CompletedIndiana University2692026-02-182026-08-19

Showing 20 of 782. Sign in to see all of them.

Conditions studied

Cataract (138)  ·  Glaucoma, Open-Angle (116)  ·  Dry Eye Syndromes (113)  ·  Ocular Hypertension (112)  ·  Refractive Errors (103)  ·  Glaucoma (102)  ·  Myopia (97)  ·  Astigmatism (62)  ·  Presbyopia (41)  ·  Hyperopia (27)  ·  Aphakia (24)  ·  Macular Degeneration (22)  ·  Conjunctivitis, Allergic (21)  ·  Hypertension (17)  ·  Conjunctivitis (9)

Interventions

Travoprost (66)  ·  Ophthalmic Solutions (49)  ·  brinzolamide (38)  ·  Timolol (32)  ·  Latanoprost (29)  ·  Cataract Extraction (25)  ·  anecortave acetate (25)  ·  Duotrav (19)  ·  Olopatadine Hydrochloride (19)  ·  Brimonidine Tartrate (16)  ·  Dexamethasone (14)  ·  Azarga (13)  ·  Contact Lenses (11)  ·  Lubricant Eye Drops (10)  ·  Moxifloxacin (10)

Countries

United States (392)  ·  Canada (31)  ·  Australia (21)  ·  Japan (19)  ·  United Kingdom (18)  ·  Spain (13)  ·  India (10)  ·  Germany (9)  ·  China (8)  ·  France (8)  ·  Brazil (7)  ·  Italy (6)  ·  South Korea (5)  ·  Taiwan (5)  ·  Netherlands (4)

Top investigators

Abayomi Ogundele, PharmD (6)  ·  Joachim Nick, Dipl. Ing. (6)  ·  Lawrence A. Yannuzzi, MD (6)  ·  Lyndon Jones, PhD, FCOptom (6)  ·  Theresa Landry (6)

Results publications

PMID 21681652, PMID 21750611, PMID 27388251, PMID 27466061, PMID 30986442, PMID 32600261, PMID 33207259, PMID 34968756, PMID 35749069, PMID 39033924, PMID 42210509, PMID 11589866, PMID 14508260, PMID 14736774, PMID 14996520, PMID 16196117, PMID 17191187, PMID 17415690, PMID 18289898, PMID 18414108, PMID 18500088, PMID 18538406, PMID 18695101, PMID 18703943, PMID 18826749, PMID 19049301, PMID 19084273, PMID 19157559, PMID 19365194, PMID 19426959, PMID 19506189, PMID 19668532, PMID 19668762, PMID 19683191, PMID 20065212, PMID 20457949, PMID 20505839, PMID 20592230, PMID 20631232, PMID 20688734, PMID 21048504, PMID 21138337, PMID 21310379, PMID 21477426, PMID 21498612, PMID 21704965, PMID 21724047, PMID 21773673, PMID 21925737, PMID 22084157

NIH funding

2005 (2), 2008 (2), 2014 (2), 2016 (2), 2015 (1), U10EY013272 (1)